• Health & Medicine

First immunotherapy approved for cervical cancer in England and Scotland

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

16 May 2023

• Policy & Insight

Elliot Colburn MP: Why Cancer Research UK’s Manifesto for Cancer Research and Care matters to me

Elliot Colburn MP, and Chair of the All-Party Parliamentary Group on Cancer, on why he supports Cancer Research UK’s work on a Manifesto for Cancer Research and Care – a blueprint which aims to help transform cancer care in this country Elliot Colburn MP, and Chair of the All-Party Parliamentary Group on Cancer, on why he supports Cancer Research UK’s work on a Manifesto for Cancer Research and Care – a blueprint which aims to help transform cancer care in this country

9 May 2023

• Science & Technology

How MRI add-ons could accelerate the development of new treatments

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

9 May 2023

• Policy & Insight
• Health & Medicine

People who’ve had radiotherapy shape our new policy calls

On the back of a recent survey, our new policy position statement on radiotherapy turns patient experiences into recommendations for the Government and the NHS. On the back of a recent survey, our new policy position statement on radiotherapy turns patient experiences into recommendations for the Government and the NHS.

4 May 2023

• Health & Medicine

Severe mental illness linked to low attendance at cancer screening

New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions. New research has found that adults with severe mental illness are less likely to attend cancer screening than those who do not have such conditions.

4 May 2023

• Science & Technology

TRACERx: Using blood tests to track lung cancer

In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples.  In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples. 

1 May 2023

• Health & Medicine

How longer waiting times are impacting teens and young adults

Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health. Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.

27 April 2023

• For Researchers

Making a startup out of a scientist

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

26 April 2023

• Science & Technology

From smouldering ash to a gleaming temple for cancer research: The new home of Cancer Research UK's Manchester Institute

Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place. Martin McGlown, our head of regional media relations, reflects on the 2017 Cancer Research UK Manchester Institute fire and the new research centre that has been rebuilt in its place.

26 April 2023

• Health & Medicine

FOCUS4: Learning from a landmark clinical trial

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

25 April 2023